Insights from 2023 ASCO® Annual Meeting
M

ASCO® 2023 Insights: "Efficacy, Safety, & PROs From the Phase III IMbrave050 Trial - Adjuvant Atezo + Bev vs. Active Surveillance in HCC Patients With High Risk of Disease Recurrence Following Resection or Ablation"

By Insights from 2023 ASCO® Annual Meeting FEATURING Masatoshi Kudo
By Insights from 2023 ASCO® Annual Meeting FEATURING Masatoshi Kudo
268 views
June 14, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
22:55
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…

Feat. R. Kim, R. Mehta
26:59
University of Texas Southwestern Medical Center

2023 AASLD Guidance for HCC

Feat. A. Singal
16:40
Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi
10:57
UCLA Health

Y90 Radioembolization for Locally Advanced HCC

Feat. S. Padia
22:02
ACG 2023 Conference Coverage

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

Feat. R. Wong
13:58
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 &am…

Feat. R. Kim, T. Biachi
14:14
Stanford Medicine

HCC: Updates in Management

Feat. R. Dhanasekaran
08:24
Yale Cancer Center

GI Oncology Year in Review: Hepatobiliary Cancers

Feat. P. Kunz
14:54
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…

Feat. L. Rimassa
28:59
The France Foundation

Evolving Options for the Treatment of HCC With IO and Liver-Directed…

Feat. A. Smolock, B. George
19:39
The France Foundation

Systemic Treatment Landscape for Advanced HCC: Case Discussion - 40 …

Feat. A. Burgoyne, S. Stein
07:19
Cleveland Clinic Taussig Cancer Institute

Clinical Implications of the HIMALAYA Study: Safety & Efficacy o…

Feat. S. Kamath
09:23
Johns Hopkins

Advancements in Systemic Therapy for Advanced HCC: Where Are We Going

Feat. M. Yarchoan
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

31:47
UChicago Medicine

Multidisciplinary Approach to Hepatobiliary Malignancies: A Changing…

Feat. A. A. Pillai
16:10
Malkhaz Mizandari

HCC Percutaneous Radio-Ablation Using BAT-90: Results of an Ongoing …

67:58
Scripps Health

Advances in Hepatocellular Carcinoma Diagnosis and Treatment

Feat. A. Singal
09:16
Ahmed O. Kaseb

Current Unmet Needs in Advanced HCC

05:50
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "KEYSTEP-004 Study - Coformulated Quavo…

Feat. L. Rimassa